Collagen stimulator or HA filler: which one fits your timeline?

The upper cheek looks a little emptier than it used to, and there's a shadow at the temple that wasn't there two years ago. Then you start reading, and the choice splits in two: something that fills on the day, and something that asks your own tissue to build the volume over several months.

The long-lasting option sounds appealing right up until you read that nothing much changes at the appointment. The immediate option sounds easy right up until you read how often you'd be back. Ask which is better and the answer comes back as "it depends", which is true and completely unhelpful when you're trying to book something.

So here's what the literature actually records: how the two produce volume by different routes, what a head-to-head trial measured at four weeks versus 48 weeks, and which question a consultation settles first.

This article organizes treatment information to STON Clinic standards. Individual results vary, and whether a treatment suits you is a decision to make with a board-certified dermatologist.

Two materials, two completely different routes to volume

Two materials, two completely different routes to volume

They aren't two brands of the same thing. The route by which volume appears is different, and that difference drives almost every practical decision that follows.

A 2020 study in a dermatology journal describes hyaluronic acid as a glycosaminoglycan and natural compound of the extracellular matrix that increases skin hydration and fibroblast proliferation by activating fibroblasts to express type I collagen. In practice, the gel you inject holds water, and the water is the volume.

The same paper describes poly-L-lactic acid differently. It's a biocompatible, biodegradable, immunologically inert synthetic polymer that stimulates collagen synthesis, and as the microparticles degrade, the inflammatory reaction responsible for breaking them down promotes fibrous connective tissue and neocollagenesis*. The authors add one line that's worth reading twice: the result is not the effect of the product, but of the host's response to this process.

Neocollagenesis: new collagen your own skin lays down. What fills the space isn't the injected material but what your tissue builds around it

That single sentence explains the waiting. If the volume is your own collagen, it appears on your body's schedule, not the injector's. And it's why the first useful question in a consultation isn't which material is stronger, it's when you need to look a particular way.

Two materials, two completely different routes to volume

What a head-to-head trial recorded at four weeks and at 48

What a head-to-head trial recorded at four weeks and at 48

The clearest comparison to date is a multicenter, randomized, double-blind trial published in an aesthetic surgery journal in 2026. It enrolled 252 participants across eight centers in China, treating moderate-to-severe nasolabial folds with either poly-L-lactic acid microspheres or hyaluronic acid.

At 48 weeks the effective correction ratio was 92.4% for PLLA against 59.3% for HA, a difference of 33.1 percentage points. That headline number is the reason collagen stimulators get described as longer-lasting.

The more useful finding is what happened before that. The same trial records that HA outperformed PLLA at week four, reflecting its immediate effect, and that PLLA showed superior outcomes from week 36 onward. It also notes that PLLA required more frequent early treatments, while HA generally achieved correction in fewer sessions. Adverse events in both arms were mild and transient.

The authors don't pick a winner. Their conclusion is that HA offers rapid improvement while PLLA requires multiple early sessions but yields more durable correction up to 48 weeks with similar safety, and that filler selection should be individualized according to patient priorities.

It's also worth knowing that "collagen stimulator" covers a family, not a single material. A 2026 narrative review of 22 clinical studies groups poly-L-lactic acid, poly-D,L-lactic acid, polycaprolactone and calcium hydroxyapatite together as biostimulators, and records that polycaprolactone induces durable neocollagenesis lasting up to 24 months with supporting neovascularization. All four, the review notes, trigger a controlled inflammatory response characterized by macrophage infiltration.

Here's how the two approaches line up.

That last row carries real weight. Having a second move available if the shape isn't right is a different proposition from waiting for time to soften it, and it changes what you're agreeing to at the first appointment.

Nodules are the risk that moves most with technique

Nodules are the risk that moves most with technique

Both materials have a good safety record, and the 2026 review found adverse events predominantly mild and transient. But it also records that nodule formation is most notable with PLLA, at 4.7% to 28.6%.

A range that wide is itself the finding. When reported rates vary six-fold, the variable isn't the material, it's what's done with it.

A 2026 scoping review of 40 studies on PLLA nodules says as much directly. It records that nodule formation appeared to be linked to the dilution protocol, injection technique, reconstitution method and injection depth, identifies four clinical phenotypes — non-inflammatory, inflammatory-immunologic, infectious-biofilm, and unusual presentations — and lists ultrasound and high-frequency ultrasound as useful diagnostic aids. Its closing line is that effective management appears to begin with prevention.

The same review notes that early practice diluted the lyophilized powder with only 2 to 3 mL of sterile water, which was associated with a very high rate of nodule formation, and that later changes to dilution, injection technique and post-treatment massage significantly improved the safety profile. So dilution volume isn't a technical footnote. It's part of what you're choosing.

Why STON Clinic matches the timeline before talking about duration

Why STON Clinic matches the timeline before talking about duration

The first question here isn't how long you want it to last. It's where you need to be, and when.

That's deliberate, and it comes straight out of the trial data. An option that pulls ahead from week 36 does nothing for a photograph four weeks away. Recommend it anyway and the literature's main advantage never shows up inside your actual timeline. Run the opposite mistake — a short-interval plan for someone who cares about how they look a year from now — and you've only added appointments.

So the consultation starts with dates. Anything in the next three, six or twelve months that matters goes on paper first, and the material follows from that.

Why STON Clinic matches the timeline before talking about duration

Next comes what's already in your face. Where, when, how much, whether anything has been dissolved, whether a lump has ever been felt. If something is still sitting in the deep layer, the decision about adding to that same spot changes.

Then the records. Dilution volume and injection depth go in the chart and get carried into the next session, because those are exactly the variables the nodule review ties to outcomes. Results and reactions vary between people, and the plan is set in consultation with a dermatologist rather than from an article.

What to bring to a consultation

What to bring to a consultation

Start with your injection history. Dates, sites, materials, any dissolving, any lump or visible edge. If the details are fuzzy, receipts and booking confirmations usually fill the gaps better than memory does.

Then your calendar for the next year. Photographs, events, travel, anything where you'd rather not be mid-change. More of the decision rests on this page than most people expect.

Last, photos of today. Front and both profiles under indoor lighting, plus one looking slightly up, because shadow at the cheek and temple shifts dramatically with the light source. Without a baseline you can't see change, only remember it differently.

And one safety note worth separating from the cosmetic conversation: sudden pain at an injected site, skin that blanches white, or any change in vision needs same-day medical care, not a follow-up consultation.